India Demonstrates Strong Market Potential with Rising Obesity Prevalence Revenue from obesity GLP-1 treatment in India is expanding at a CAGR of 28.4%, supported by increasing obesity rates in metropolitan areas and growing awareness of cardiovascular risk factors
GLP-1 is produced naturally by specialized cells in your intestines in response to food intake
Block quote Ordered list Item 1 Item 2 Item 3 Unordered list Item A Item B Item C Bold text Emphasis Superscript Subscript Heading Heading 1 Heading 2 Heading 3 Heading 4 Heading 5 Heading 6 Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
Less common (tell your doctor): Gallbladder pain, raised heart rate, signs of pancreatitis (rare)
Un plan de nutricin y ejercicio previo prepara el cuerpo y mejora la respuesta al tratamiento combinado
However, the incidence of CRC is not considerably high. More research and longer-term studies were recommended